ArticleHuman cell2025

Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway.

Zhao Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.